# Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma

> **NCT02011594** · PHASE2 · WITHDRAWN · sponsor: **Zhejiang University**

## Conditions studied

- Stage IV Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** Nimotuzumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02011594
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** There was no participants enrolled in this clinical trial.
- **Last updated:** 2015-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02011594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02011594, "Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02011594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*